Floatz logo

4-phenylbutyrate

Cholestasis, Intrahepatic

Children's Hospital of Fudan UniversityPhase 2/3Active
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cholestasis, Intrahepatic cohort.

Asset / SponsorPhaseRating
Linerixibat
GlaxoSmithKline
Phase 2B
URSODEOXYCHOLIC ACID
GlaxoSmithKline
Phase 2B

Same molecule, other indications

4-phenylbutyrate is also rated in:

hereditary diseaseDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →